535 related articles for article (PubMed ID: 17496787)
1. Diagnosis and treatment of cutaneous melanoma: state of the art 2006.
Garbe C; Eigentler TK
Melanoma Res; 2007 Apr; 17(2):117-27. PubMed ID: 17496787
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and treatment protocols of cutaneous melanoma: latest approach 2010.
Petrescu I; Condrea C; Alexandru A; Dumitrescu D; Simion G; Severin E; Albu C; Albu D
Chirurgia (Bucur); 2010; 105(5):637-43. PubMed ID: 21141087
[TBL] [Abstract][Full Text] [Related]
3. Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma.
Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R
Melanoma Res; 2007 Dec; 17(6):393-9. PubMed ID: 17992123
[TBL] [Abstract][Full Text] [Related]
4. New TNM melanoma staging system: linking biology and natural history to clinical outcomes.
Balch CM; Buzaid AC; Soong SJ; Atkins MB; Cascinelli N; Coit DG; Fleming ID; Gershenwald JE; Houghton A; Kirkwood JM; McMasters KM; Mihm MF; Morton DL; Reintgen DS; Ross MI; Sober A; Thompson JA; Thompson JF
Semin Surg Oncol; 2003; 21(1):43-52. PubMed ID: 12923915
[TBL] [Abstract][Full Text] [Related]
5. [The latest diagnostical methods and therapy in melanoma].
Wojas-Pelc A; Rajzer L; Jaworek A; Woźniak W
Przegl Lek; 2006; 63(8):674-80. PubMed ID: 17441381
[TBL] [Abstract][Full Text] [Related]
6. Selection of patients for long-term surveillance with digital dermoscopy by assessment of melanoma risk factors.
Haenssle HA; Korpas B; Hansen-Hagge C; Buhl T; Kaune KM; Johnsen S; Rosenberger A; Schön MP; Emmert S
Arch Dermatol; 2010 Mar; 146(3):257-64. PubMed ID: 20231495
[TBL] [Abstract][Full Text] [Related]
7. Malignant melanoma in the lower extremity. A comprehensive overview.
Hutchinson BL
Clin Podiatr Med Surg; 1986 Jul; 3(3):533-50. PubMed ID: 2943398
[TBL] [Abstract][Full Text] [Related]
8. Malignant melanoma S3-guideline "diagnosis, therapy and follow-up of melanoma".
Pflugfelder A; Kochs C; Blum A; Capellaro M; Czeschik C; Dettenborn T; Dill D; Dippel E; Eigentler T; Feyer P; Follmann M; Frerich B; Ganten MK; Gärtner J; Gutzmer R; Hassel J; Hauschild A; Hohenberger P; Hübner J; Kaatz M; Kleeberg UR; Kölbl O; Kortmann RD; Krause-Bergmann A; Kurschat P; Leiter U; Link H; Loquai C; Löser C; Mackensen A; Meier F; Mohr P; Möhrle M; Nashan D; Reske S; Rose C; Sander C; Satzger I; Schiller M; Schlemmer HP; Strittmatter G; Sunderkötter C; Swoboda L; Trefzer U; Voltz R; Vordermark D; Weichenthal M; Werner A; Wesselmann S; Weyergraf AJ; Wick W; Garbe C; Schadendorf D; ;
J Dtsch Dermatol Ges; 2013 Aug; 11 Suppl 6():1-116, 1-126. PubMed ID: 24028775
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous melanoma in the elderly: epidemiology, prognosis and treatment.
Lasithiotakis KG; Petrakis IE; Garbe C
Melanoma Res; 2010 Jun; 20(3):163-70. PubMed ID: 20375923
[TBL] [Abstract][Full Text] [Related]
10. Variations in management of stage I to stage III cutaneous melanoma: a population-based study of clinical practices in France.
Grange F; Vitry F; Granel-Brocard F; Lipsker D; Aubin F; Hédelin G; Dalac S; Truchetet F; Michel C; Batard ML; Baury B; Halna JM; Schmutz JL; Delvincourt C; Reuter G; Dalle S; Bernard P; Danzon A
Arch Dermatol; 2008 May; 144(5):629-36. PubMed ID: 18490589
[TBL] [Abstract][Full Text] [Related]
11. [Cutaneous melanoma].
Eigentler TK; Mügge LO; Bembenek A; Garbe C
Hautarzt; 2007 Oct; 58(10):885-97; quiz 898. PubMed ID: 17973138
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous melanoma and intervention strategies to reduce tumor-related mortality: what we know, what we don't know, and what we think we know that isn't so.
Rhodes AR
Dermatol Ther; 2006; 19(1):50-69. PubMed ID: 16405570
[TBL] [Abstract][Full Text] [Related]
13. Improvement of overall survival of patients with cutaneous melanoma in Germany, 1976-2001: which factors contributed?
Lasithiotakis KG; Leiter U; Eigentler T; Breuninger H; Metzler G; Meier F; Garbe C
Cancer; 2007 Mar; 109(6):1174-82. PubMed ID: 17265520
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant high-dose interferon-alpha therapy for high-risk melanoma.
Kirkwood JM; Tarhini AA
Forum (Genova); 2003; 13(2):127-40; quiz 187-8. PubMed ID: 14732880
[TBL] [Abstract][Full Text] [Related]
15. [Therapy of cutaneous melanoma].
Dummer R; Nestle FO; Hofbauer G; Böni R; Burg G
Ther Umsch; 1998 Aug; 55(8):509-14. PubMed ID: 9757818
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous melanoma: update on prevention, screening, diagnosis, and treatment.
Rager EL; Bridgeford EP; Ollila DW
Am Fam Physician; 2005 Jul; 72(2):269-76. PubMed ID: 16050450
[TBL] [Abstract][Full Text] [Related]
17. Multidisciplinary treatment of primary melanoma.
Yao K; Balch G; Winchester DJ
Surg Clin North Am; 2009 Feb; 89(1):267-81, xi. PubMed ID: 19186240
[TBL] [Abstract][Full Text] [Related]
18. Changing trends in melanoma treatment and the expanding role of the dermatologist.
Brown MD; Johnson TM; Swanson NA
Dermatol Clin; 1991 Oct; 9(4):657-67. PubMed ID: 1934641
[TBL] [Abstract][Full Text] [Related]
19. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
Nowecki ZI; Rutkowski P; Michej W
Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
[TBL] [Abstract][Full Text] [Related]
20. Is detection of melanoma metastasis during surveillance in an early phase of development associated with a survival benefit?
Leiter U; Buettner PG; Eigentler TK; Forschner A; Meier F; Garbe C
Melanoma Res; 2010 Jun; 20(3):240-6. PubMed ID: 20216239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
